The detection rates of mutations of <i>KRAS</i>, <i>TP53</i>, <i>CDKN2A</i>, and <i>SMAD4</i>. Tetsuya Ishizawa Naohiko Makino Akiko Matsuda Yasuharu Kakizaki Toshikazu Kobayashi Chisaki Ikeda Shinpei Sugahara Michihiko Tsunoda Yoshiyuki Ueno 10.1371/journal.pone.0228565.g002 https://plos.figshare.com/articles/figure/The_detection_rates_of_mutations_of_i_KRAS_i_i_TP53_i_i_CDKN2A_i_and_i_SMAD4_i_/11772753 <p>The detection rates of mutations of <i>KRAS</i>, <i>TP53</i>, <i>CDKN2A</i>, and <i>SMAD4</i>.</p> 2020-01-30 18:40:08 KRAS mutation analysis retrospective study Pancreatic cancer 2A 2017. DNA sequences cancer gene panel testing SMAD CDKN endoscopic ultrasound-guided fine-needle aspiration polymerase chain reaction NGS ROSE specimens unresectable PC patients 5- year survival rate KRAS mutations TP Ion AmpliSeq Comprehensive Caner Panel